Tags: Prostate Health | genomic prostate score | facts

5 Facts About the Genomic Prostate Score

By    |   Tuesday, 16 Feb 2016 04:09 PM

Every 20 minutes in the U.S., a man dies from prostate cancer. The genomic prostate score (GPS) is an important way to better understand each individual’s cancer and determine the appropriate treatment path.

Here are some helpful facts about the genomic prostate score.

SPECIAL: The One Thing You Should Do for Your Prostate Every Morning

1. According to Zero Cancer, genomic testing relies on cancerous tissue samples taken from the prostate gland. The cells are analyzed to determine how aggressive a patient’s cancer is and how quickly it is likely to spread to other parts of the body.

2. The genomic prostate score is the result of a test called the Oncotype DX prostate cancer test, says MyProstateCancerTreatment.org. The score helps guide physicians in developing the best customized treatment plan for each patient.

3. MyProstateCancerTreatment.org explains that the genomic prostate score, together with another set of guidelines set forth by the National Comprehensive Cancer Network, are used to determine the level of risk for a patient’s prostate cancer. Very high-risk cancer patients are generally not candidates for the Oncotype DX test, however.

ALERT: Prostate Size Can Greatly Affect Quality of Life and Sleep. What Size Is Yours? See This Photo.

4. The University of California San Francisco says that for men with very low-risk, non-aggressive prostate cancer, a strategy called active surveillance is a viable approach. With active surveillance, the cancer is not actually treated. Instead it is closely monitored through blood tests and biopsies to determine if and when treatment becomes necessary. The genomic prostate score can help physicians determine which prostate cancer patients are good candidates for this approach, saving patients from the adverse side affects associated with invasive treatment.

Prostate cancer is a significant health concern for men. The Oncotype DX test and the genomic prostate score is an emerging means of assessing risk, customizing treatment plans, and ensuring that patients get the appropriate level of care for their cancer.

EDITOR'S NOTE: How One Household Plant Has Been Shown to Improve Prostate Function

© 2017 Newsmax. All rights reserved.

 
1Like our page
2Share
FastFeatures
Every 20 minutes in the U.S., a man dies from prostate cancer. The genomic prostate score (GPS) is an important way to better understand each individual's cancer and determine the appropriate treatment path.
genomic prostate score, facts
338
2016-09-16
Tuesday, 16 Feb 2016 04:09 PM
Newsmax Inc.
 

Newsmax, Moneynews, Newsmax Health, and Independent. American. are registered trademarks of Newsmax Media, Inc. Newsmax TV, and Newsmax World are trademarks of Newsmax Media, Inc.

NEWSMAX.COM
America's News Page
© Newsmax Media, Inc.
All Rights Reserved